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1. Introduction 
Inflammatory bowel disease (IBD) – a generic term for Crohn’s disease (CD) and ulcerative 
colitis (UC) – represents great risks for inheritance, such as high sibling recurrent risks (ǌs in 
CD and UC: 20-35 and 8-15) and high monozygotic concordance rates (50% to 60%). Recent 
genome-wide association studies (GWAS) have successfully identified many causative 
genes (risk variants) for IBD. These discoveries highlight the importance of autophagy and 
innate immunity as determinants of dysregulated host-commensal bacteria interactions in 
the intestine. Some of the risk-variants are shared between CD and UC, indicating both 
similarities and differences in their etiologies. Most of the IBD risk-variants, however, have 
been reported in European-ancestry populations, and these associations are not always 
reproduced in non-European ancestry populations, suggesting a population-specific 
susceptibility to IBD. In fact, some of the IBD risk variants showed no association with CD 
and UC in East Asians. Hence, IBD’s causative factors should be defined as genetically 
different between Europeans and East Asians; it is essential that we expand GWAS into non-
European populations so as to unravel the causes of its population-specific susceptibility and 
identify IBD risk variants in each geographic population. It is widely an accepted idea that the 
risk variants of complex diseases, including IBD, are retained not only in patients, but also in 
healthy controls. Because the risk variants spread prevalently into geographically diverse 
populations, it is plausible that their origins could be dated before Homo sapiens’ expansion out 
of Africa; that is, the fate of risk variants must be affected by human population history, such 
as demography, migration and natural selection. Here, we suggest that an evolutionary 
perspective of IBD genomics could provide essential clues for resolving significant questions: 
(1) Do the risk-variants have similar allele frequencies in different populations?  (2) How are 
the risk-variants prevalent in human populations?  (3) What factors can cause the 
inconsistency of GWAS-results across geographic populations?  In this chapter, we first 
provide an overview of the evolutionary characteristics of disease-causative variants in 
Mendelian diseases and complex diseases. Secondly, we review the recent progress of IBD 
genetic/genomic studies among both European and East Asian populations. Finally, we 
discuss the evolutionary consequences of population-specific susceptibility to IBD and the 
importance of its use for diverse human populations in the future of GWAS. 
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2. Genetic studies of IBD and population-specific susceptibility 
IBDs are complex diseases in which multiple genetic and environmental factors are likely to 
contribute to pathogenesis. Human genomics studies have concentrated their attention on 
the identification of the genetic variants underlying these diseases over the past decade, 
since none of the complex diseases are inherited in a simple Mendelian fashion. The genetic 
characteristics of variants are significantly different between Mendelian (monogenic) 
diseases and complex (multi-factorial) diseases, both of which constitute the basis of genetic 
mapping strategies (e.g., linkage analysis and case-control association studies) for the 
revelation of their role in the aetiology of clinically defined phenotypes. Disease alleles are a 
specific subset of all the genetic variants present in human populations, and the origin of 
diseases can be addressed by population genetics modelling from the geographic 
distribution of disease variants. We first summarize some general approaches to identify 
disease alleles and the evolutionary characteristics of the variants, and we then introduce 
the recent genetic studies of IBD. 
2.1 Genetic and evolutionary characteristics of diseases variants 
Genetic mapping provides a powerful approach to identify genes and the biological 
processes underlying human diseases. From a vast amount of human genetic variations, a 
number of efforts have been made to identify those responsible for Mendelian diseases 
through linkage analysis. This method looks for a correlation between segregation (i.e. 
linkage) and phenotype within family pedigrees by using DNA sequence variants as genetic 
markers, without the need for prior an assumption about biological function. Since the 
causative variants for Mendelian diseases show high penetrance (proportion of individuals 
with a particular genotype who manifest a given phenotype), they tend to be transmitted 
into familial members in the Mendelian fashion. Thus, Mendelian diseases often feature a 
low frequency of causative mutations (< 1%: rare variants) (Fig. 1a). 
In contrast to Mendelian diseases, much less success has been achieved using linkage-based 
approaches for complex diseases (Risch and Merikangas 1996; Risch 2000; Altmuller et al. 
2001). A single copy of the risk allele is sufficient to cause a Mendelian disease in the 
autosomal dominant pedigree, whereas the risk allele is neither sufficient nor necessary for 
complex diseases to occur (Knight 2009). The lack of Mendelian segregation of a complex 
disease in most families argues against the sufficiency of a mutation in any one gene 
(Chakravarti 1999). As alternative approaches to tracing transmission in families, one might 
localize disease‘s genes through association studies that compare the frequencies of genetic 
variants among affected and unaffected individuals. Based on a set of single nucleotide 
polymorphisms (SNPs) – which usually consists of several hundred thousand markers – a 
number of efforts have been made in GWAS. These scans show that the susceptibility 
variants involved in complex diseases have low or medium penetrance (i.e. incomplete 
penetrance) so that the disease variants are carried by healthy individuals, as well as by 
patients (Fig. 1a). 
Based on these genetic properties of alleles, we can address the origins of disease variants in 
terms of evolutionary genetics. Mendelian diseases – which are usually due to highly 
penetrant and deleterious alleles that segregate in specific families – fit relatively simple 
equilibrium models of mutation-selection balance, in which disease alleles are removed by 
purifying selection and continually appearing through the mutation process (Di Rienzo 
2006). These disease mutations are likely to have occurred relatively recently in human  
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Fig. 1. The genetic properties of Mendelian disease and complex disease alleles. (a) 
Mendelian disease alleles have a high penetrance and their frequencies are very rare. In 
contrast, complex disease alleles are present both in patients and healthy controls in a 
population. This figure is modified from Box 7 in McCarthy et al. (2008). (b) The schematic 
diagram of human evolutionary history shows that anatomically modern humans 
originated in Africa around 200 thousand years ago (KYA). A small subset of ancestral 
populations dispersed from Africa around 150 to 100 KYA and then separated into 
Europeans and East Asians around 70 to 20 KYA. Mendelian disease alleles are likely to be 
recent mutations, while complex disease alleles – including common alleles and population-
specific alleles – appeared before human population divergences 
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history (Fig. 1b). However, this equilibrium model is not applied to complex diseases, 
because of incomplete penetrance, gene-to-environmental interactions and polygenic 
inheritance. Most of the complex disease alleles spread across human populations, and these 
variants appeared before the divergence of populations. The complex disease alleles 
identified from GWAS are most common among geographically separated populations (e.g. 
Africans, Europeans and East Asians) (light-blue stars in Fig. 1b). Another phase of GWAS 
would be needed to focus on population-specific alleles (green stars in Fig. 1b) because of 
missing heritability (i.e. many of the genetic factors thought to be responsible for complex 
diseases can only explain between 5% and 50% of the diseases‘ heritability) and population-
specific susceptibility. Specifically, these alleles have been jointly exposed to selective 
pressures and human demography, both of which are specific events to a particular 
geographic population. We describe population differences in susceptibility to IBD between 
Europeans and Japanese, and discuss evolutionary insights into the susceptibility to IBD. 
2.2 Genetic studies of IBD in “European-ancestry populations” 
Several studies have shown that an individual with IBD is more likely to have a relative 
with the disease (Budarf et al. 2009). Population-based studies find that 5-10% of patients 
have a first-degree family member with IBD, with the calculated sibling recurrence risk (ǌs: 
the ratio of the risk for the siblings of a patient to develop the disease compared to the risk 
for a general member of the same population) estimated to be 30-40 fold for CD and 10-20 
fold for UC. The concomitant rate is significantly greater for monozygotic individuals than 
for dizygotic twins, for both CD (50-58% versus 0-12%) and UC (6-14% versus 0-5%) (Binder 
1998). Hence, there are strong genetic contributions towards the risk of IBD, and especially 
for CD. 
2.2.1 Genetic studies of CD 
Generally, most of family-based studies have had limited success in finding genes for 
complex diseases, because of the non-Mendelian inheritance for the disease phenotypes. 
Nevertheless, linkage and positional cloning approaches have identified a nucleotide-
binding oligomerization domain containing 2 (NOD2, also designated CARD15 and IBD1) as 
the first susceptible gene for CD (Hugot et al. 2001; Ogura et al. 2001a). Moreover, the IBD5 
risk haplotype was identified from the linkage disequilibrium (LD) mapping of trios, and 
the risk haplotype included functionally interesting candidate genes: prolyl 4-hydroxylase 
(P4HA2), the interferon regulatory factor 1 (IRF1), and the organic cation transporter 
(OCTN) gene cluster (SLC22A4 and SLC22A5, encoding OCTN1 and OCTN2, respectively) 
(Rioux et al. 2001; Peltekova et al. 2004). Since then, GWAS have been substantially 
improving our understanding of the biological pathways underlying the pathogenesis of 
CD, since the genetic contribution to CD is greater than to UC. A recent meta-analysis of the 
pooled data for six independent GWAS comprising 6,333 individuals with CD and 15,056 
controls has reported 71 susceptibility loci (30 new susceptibility loci) to CD (Franke et al. 
2010), and replicated the previously validated associations, including NOD2 and IBD5, as 
well as other CD genes identified from several independent GWAS (Yamazaki et al. 2005; 
Duerr et al. 2006; Hampe et al. 2007; Libioulle et al. 2007; Parkes et al. 2007; Raelson et al. 
2007; Rioux et al. 2007; The Wellcom Trust Case Control Consortium 2007; Barrett et al. 2008; 
Kugathasan et al. 2008). Therefore, the advent of GWAS has dramatically increased the 
number of susceptibility loci to CD in people of European descent. 
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2.2.2 Genetic studies of UC 
CD and UC share many diagnostic features, and relatives with CD or UC are likely to be at 
an increased risk of developing either form of IBD, indicating the existence of both 
phenotype-specific and shared susceptibility loci for CD and UC. Before GWAS in UC, 
candidate gene approaches to the susceptibility loci identified in CD were conducted in UC. 
It was shown that several genes – including the interleukin-23 receptor (IL23R), the NK2 
transcription-factor-related, locus 3 (NKX2-3) and the macrophage stimulating 1 (MST1) – 
were also significantly associated with UC, whereas the other representative genes in CD, 
such as NOD2, showed no susceptibility to UC (Fisher et al. 2008; Franke et al. 2008). 
Subsequently, GWAS – as well as these candidate gene association studies – have identified 
18 susceptibility loci for UC, including established risk loci specific to UC, such as the 
hepatocyte nuclear factor 4ǂ (HNF4A), the cadherin 1 (CDH1) and the laminin ǃ1 subunit 
(LAMB1) that are highlighted with the role of defective barrier function in UC pathogenesis 
(Barrett et al. 2009). A meta-analysis of six GWAS datasets of UC, comprising 6,687 cases 
and 19,718 controls, has identified 29 additional risk loci, increasing the number of UC loci 
to 47 (Anderson et al. 2011). The total number of confirmed IBD risk loci is about 99, and a 
minimum of 28 show shared association signals between CD and UC. Thus, recent GWAS 
successes have accelerated our knowledge about the commonalities and unique features of 
the aetiology between CD and UC. 
2.3 Genetic studies of IBD in Japanese (“non-European-ancestry”) populations 
Many GWAS’s efforts to identify susceptibility genes of IBD have been successful in 
European-ancestry populations, and recent advances have provided substantial insights into 
the maintenance of mucosal immunity and the pathogenesis of IBD (Xavier and Podolsky 
2007). Furthermore, some of the IBD variants have also had their pathogenic roles 
demonstrated by in vivo and in vitro functional studies. NOD2, one of the established 
susceptibility genes to CD (Hugot et al. 2001; Ogura et al. 2001b), encodes a protein that 
recognizes pathogen-associated molecular patterns: common motifs of the peptidoglycan 
product muramyl dipeptide (MDP), which modulates both innate and adaptive immune 
responses (Shaw et al. 2011). The cytosine insertion in NOD2 exon 11 (3,020C) results in a 
frameshift and generates a truncated NOD2 protein (1,007 of 1,040 amino acid residues), 
which induces impaired activation of the transcriptional factor NF-ǋB (Chamaillard et al. 
2003). For ATG16L encoding a key autophagy molecule, the patients with a homozygote of 
alanine at 300 amino acid residues (T300A) display disorganised or diminished granules in 
Paneth cells, which are specialised epithelial cells for controlling the intestinal environment by 
the release of granules (Cadwell et al. 2008). Several additional lines of evidence, including 
transgenic mouse experiments for the susceptibility genes (Cadwell et al. 2008; Cadwell et al. 
2010; Travassos et al. 2010), show a functional deficiency of CD variants. However, significant 
associations between these genomic regions and IBD have not been detected in non-European 
populations, suggesting that there is a population-specific susceptibility to IBD. 
The incidence of IBD has been increasing substantially within the Japanese population. The 
prevalence rate has risen seven times between 1,985 and 2,006 (Hilmi et al. 2006). The 
disease-mapping strategy of early association studies in Japan was to test the susceptibilities 
of genes reported from European-ancestry populations using Japanese IBD patients and 
controls. The candidate gene study shows that the NOD2 variants statistically and 
functionally confirmed in Europeans are completely absent – both in patients and controls – 
in the Japanese population (Yamazaki et al. 2002). This result is consistent with the other 
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East Asian populations, such as Korean (Croucher et al. 2003) and Chinese (Guo et al. 2004). 
To elucidate the similarities and differences of susceptibility to IBD between Europeans and 
the Japanese, associations with CD and UC have been tested for seven susceptible genomic 
regions, including NOD2, IL23R, ATG16L1, TNFSF15, SLC22A4, IRGM, and 10q21 
(Nakagome et al. 2010). Each of these genomic regions, which have been confirmed by 
multiple independent GWAS and the meta-analysis described above, is known to be 
associated with CD in European-ancestry populations. Moreover, Nakagome et al. (2010) 
have focused on a local differences in susceptibility to IBD within Japanese populations, 
because the population stratification (differences in allele frequencies between sub-populations 
due to different ancestry) is observed between Honshu (the eastern area of Japan’s main-
island) and Kyushu-Okinawa (the southwestern islands of the Japanese archipelago) 
(Yamaguchi-Kabata et al. 2008). Afterwards, the association of nine SNPs located in the seven 
genomic regions was examined in the Kyushu population, consisting of 130 individuals with 
CD, 82 individuals with UC, and 168 controls (Table 1), and which was also compared with 
the genotype data from the European and Honshu Japanese populations. 
2.3.1 Differences in susceptibility to IBD between Europeans and Japanese 
The samples acquired from each of the Kyushu Japanese subjects are first analysed to 
determine the genotypes of the nine SNPs, which are previously identified from the CD-
associated genomic regions (Table 1). These samples are also examined in order to 
determine any association of CD or UC with the risk alleles that had been identified in 
European-ancestry populations. Table 2 illustrates the genotype frequencies as well as allele 
frequencies between cases and controls. The p-values of the χ2 test corrected by the 
permutation test are shown in Table 3. In the Kyushu Japanese subjects, the risk alleles for 
NOD2 (rs2066844, rs2066845, rs2066847) and SLC22A4 (rs1050152) are not found to be 
present. The analysis of the IL23R (rs11209026) gene shows that the risk allele is fixed in the 
CD cases, the UC cases and the control. Thus, these SNPs are not polymorphic in the Japanese 
population, which confirms previous studies (Yamazaki et al. 2002; Yamazaki et al. 2004; 
Yamazaki et al. 2007). In contrast, the remaining four SNP sites (i.e. rs2241880, rs3810936, 
rs10065172, and rs10761659) are shown to be polymorphic (Table 2). Furthermore, three of the 
SNPs, including rs2241880 in ATG16L1, rs10065172 in IRGM, and rs10761659 in 10q21, do not 
show any significant association with either CD or UC (Table 3). Only one SNP site was found 
to be significantly associated with CD (p-value = 0.047) and UC (p-value = 0.050) is in the 
TNFSF15 gene (rs3810936). The odds ratio (OR) of the risk allele (“G” allele in rs3810936) is 
1.551 (95% CI: 1.090-2.207) for CD and 1.692 (95% CI: 1.117-2.562) for UC (Table 3). 
The differences in allele frequency between the Kyushu and Honshu subjects are further 
compared by an χ2 test that included the Kyushu (K-) CD, the Honshu (H-) CD and each 
control (2-by-2 pairs: K-CD and H-CD, K-controls and H-controls, K-CD and H-controls, K-
controls and H-CD) (Fig. 2). A significant association between TNFSF15 (rs3810936) and CD 
is detected in all pairs of CD-controls from both the Kyushu and Honshu subjects. Previous 
studies of Honshu Japanese subjects have examined a greater number of SNPs in the other 
six genome regions, compared to Nakagome et al. (2010), but do not detect a significant 
association between CD and these SNPs (Yamazaki et al. 2002; Yamazaki et al. 2004; 
Yamazaki et al. 2007; Yamazaki et al. 2009). As an exception, Yamazaki et al. (2005) 
identified TNFSF15 as a CD susceptibility gene in the Honshu subjects, due to a significant 
association (p < 0.0001) between 20 SNP sites and CD. Using the Kyushu subjects, 
Nakagome et al. (2010) supports the previous results which demonstrated that the CD  
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Table 1. Susceptibility genes of IBD 
www.intechopen.com
 T
ab
le 2. N
u
m
b
er o
f g
en
o
ty
p
es an
d
 alleles in
 th
e K
y
u
sh
u
 su
b
jects 
Susceptibility genes SNP IDs Alleles Risk allele A
a
Genotype frequency
b
CD UC Controls
AA Aa aa AA Aa aa AA Aa
NOD2 rs2066844 C/T T 0 0 100 0 0 100 0 0
rs2066845 G/C C 0 0 100 0 0 100 0 0
rs2066847 -/C C insertion 0 0 100 0 0 100 0 0
IL23R rs11209026 A/G G 100 0 0 100 0 0 100 0
ATG16L1 rs2241880 A/G G 8 40 53 7 32 61 7 39
TNFSF15 rs3810936 A/G G 49 47 4 57 34 9 39 49
SLC22A4 rs1050152 C/T T 0 0 100 0 0 100 0 0
IRGM rs10065172 T/C C 36 47 16 40 44 16 37 51
10q21 rs10761659 A/G G 54 36 10 46 44 10 47 42
a 
Associated alleles were referred from the previous studies and annotated as "A ".
b
 The genotypes were shown as "AA " homozygote of risk alleles, "Aa " heterozygote of risk and non-risk alleles, and "aa " homozygote of non-risk alleles.
w
w
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susceptibility genes identified in Europeans are not significantly associated with CD in the 
Japanese population. The data on the TNFSF15 gene using the Kyushu subjects also 
indicated a significant positive association with CD. Therefore, these results strongly 
support TNFSF15 as a CD susceptibility gene in the Japanese population. 
 
 
Fig. 2. The distributions of risk allele frequency for three SNPs (rs2241880, rs3810936, 
rs10761659) in the Kyushu and Honshu subjects. The abbreviations, K-CD, K-controls, H-CD 
and H-controls indicate Kyushu CD, Kyushu-controls, Honshu CD, and Honshu-controls. 
The asterisks above the columns indicate a significant allele frequency difference between 
cases and controls in the same region (p-values for the Kyushu subject are referred from 
Table 3 and those for the Honshu subject are referred from Yamazaki et al. (2005)). A single 
asterisk denotes p < 0.05, and double asterisks denote p < 0.01 
2.3.2 Genotype association with CD and UC 
Disease alleles on autosomes are present as heterozygote or homozygote in an individual, 
and their effects can be categorised as dominant, recessive or additive. The genotype 
association of the four polymorphic SNP sites is tested in CD or UC, respectively. No 
significant association of ATG16L1 (rs2241880), IRGM (rs10065172), or 10q21 (rs10761659) is 
observed with either CD or UC. The different significances of TNFSF15 (rs3810936) between 
CD and UC are shown in the recessive model (i.e. AA vs. Aa + aa) and the dominant model 
(i.e. AA + Aa vs. aa) (Table 3). In the recessive model, the test shows a significant association 
between the homozygote for the risk allele and UC (p-value = 0.019). The OR of the risk 
allele homozygote is determined to be 2.132 (95% CI: 1.247 – 3.644). In the dominant model, 
both the heterozygote and the homozygote for the risk allele are found to be significantly 
associated with CD (p-value = 0.025 and OR = 3.497, 95% CI: 1.341 – 9.117). Thus, the effect 
of susceptibility in the TNSF15 risk allele (rs3810936) is likely to be different between CD 
and UC of the Kyushu Japanese. 
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Susceptibility genes SNP IDs Allele (A  / a ) Genotype (AA / Aa / aa )
Recessive model (AA  vs others) D
Odds ratio Odds ratio
p -values (95% CI) p -values (95% CI) p
CD UC CD UC CD UC CD UC CD
ATG16L1 rs2241880 0.986 0.948 1.077 0.855 0.997 0.767 1.161 1.091 1.
(0.744 - 1.557) (0.551 - 1.327) (0.477 - 2.828) (0.388 - 3.068)
TNFSF15 rs3810936 0.047* 0.050* 1.551 1.692 0.232 0.019* 1.539 2.132 0.
(1.090 - 2.207) (1.117 - 2.562) (0.966 - 2.454) (1.247 - 3.644)
IRGM rs10065172 0.921 1.000 0.886 0.987 0.999 0.974 0.956 1.137 0.
(0.634 - 1.237) (0.670 - 1.454) (0.592 - 1.543) (0.660 - 1.960)
10q21 rs10761659 0.849 1.000 1.171 0.995 0.741 0.999 1.284 0.965 1.
(0.818 - 1.674) (0.664 - 1.490) (0.808 - 2.041) (0.566 - 1.644)
* 
p -values < 0.05.
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2.3.3 Differences in the Genotype Relative Risk between CD and UC 
The genotype relative risk (GRR) test (Schaid and Sommer 1993) is conducted for the SNP 
site of rs3810936 (TNFSF15) that is found to be significantly associated with CD or UC. This 
test is adopted so as to determine whether the dominant, recessive or additive model best fit 
the observed genotype frequency using the likelihood ratio test. Based on the likelihood 
method, the GRR test is modified to include unrelated individuals and also low penetrance 
variants. 
Let A be the disease-associated allele, and let a be the non disease-associated allele. The 
probability of disease is defined, conditional on the genotype at the particular SNP site, 
as: 
 
,  (1) 
where D is the event that an individual has the disease. The complex disease allele is 
retained not only in cases but also in healthy controls. Next, the probability of non-disease is 
defined, conditional on the genotype at the particular SNP site, as: 
 
,  (2) 
Assuming that a population is in the Hardy-Weinberg equilibrium, then by Bayes’ rule we 
have: 
 
,  (3) 
 
,  (4) 
where, 
 
,  (5) 
 
,  (6) 
p is the population frequency of A, q is the frequency of a, and N is the non-disease state. 
Note that the likelihood depends on four independent parameters, ┰2case, ┰1case, pcase, and f0case. 
A standard numerical maximisation procedure can then be used to find the maximum-
likelihood estimates of ┰2case, ┰1case, pcase, and f0case with the likelihood 
  
(7) 
where nAAcase, nAacase, naacase or nAAcontrol, nAacontrol, naacontrol are the observed numbers of cases or 
controls exhibiting each genotype. 
We considered the following four hypotheses: 
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i. No association of the marker with disease, H0: ┰1case = ┰2case = 1, 
ii. Dominant disease expression, HD: ┰1case = ┰2case =┰, 
iii. Recessive disease expression, HR: ┰1case = 1, 
iv. Additive disease expression, HA: ┰1case = ┰, ┰2case = 2┰. 
The maximum likelihood estimate can be found by maximising the likelihood function 
under each hypothesis with the condition: 0 < p < 1, 1 < ┰1case, 1 < ┰2case, and 0 < f0case < 1. As 
described by Scaid and Sommer (1993), we next adopted the likelihood-ratio test (LRT). The 
LRT statistics for testing the hypothesis of no association is: 
 
 
,  (8) 
The statistics for testing the hypothesis of a dominant model are: 
  
 
,  (9) 
The statistics for testing the hypothesis of a recessive model are: 
 
 
,  (10) 
Finally, the statistics for testing the hypothesis of an additive model are: 
 
 
.  (11) 
For the SNP site (rs3810936) in TNFSF15, four parameters – including ┰2case, ┰1case, pcase, and 
f0case – are inferred from the general likelihood equation so that the likelihood ratio test can 
be applied to (7). Based on these hypotheses, the CD likelihood ratio test rejects the null 
(LRT p-value = 0.005), recessive (LRT p-value = 0.024) and additive models (LRT p-value = 
0.021) (Table 4). However, the dominant model was not rejected (LRT p-value = 0.361). In 
contrast, the UC likelihood ratio test was not found to reject any of the models, most likely 
due to a lack of power. Nevertheless, the recessive model demonstrates a better fit with the 
observed genotype frequency than do the dominant and additive models (LRT p-values are 
not assessed because the same LogL value is in both the recessive and the full model). These 
results are also supported by Akaike information criterion (AIC) values, which show the 
minimum values of the CD dominant model (AIC = 540.562) and of the UC recessive model 
(AIC = 470.516) (Table 4). Thus, the statistical test for the genotype risk of rs3810936-G 
showed that the CD mGRR data best fits the dominant model, while the UC mGRR data 
best fits the recessive model. 
The similarities and differences between CD and UC are thought to be important in 
understanding the pathogenesis of each disease (Dubois and van Heel 2008). The results 
from the mGRR tests clearly show that the genotype of the rs3810936-G allele in TNFSF15 
exhibits a different effect in CD compared to UC. The risk of the rs3810936-G allele was 
determined to be comparable between CD and UC (OR: 1.551 fold in CD and 1.692 fold in 
UC) (Table 3). However, the genotype relative risk between CD and UC was found to be 
greatly different (the risk of “GA” or “GG”: 3.604 fold or 4.310 fold in C; no risk or 1.679 fold 
in UC) (Table 4). Thus, it is likely that the risk variant of TNFSF15 functions as a “dominant” 
allele in CD, whereas it functions as a “recessive” allele in UC. 
)]f)/L(p,1,1,f,┰,┰,p2log[L(=┯ 0case0case1case2case22 ˆˆˆˆ
)]f┰,┰,)/L(p,f,┰,┰,p2log[L(=┯ 0case0case1case2case21 ˆˆˆˆ
)]f,┰)/L(p,1,f,┰,┰,p2log[L(=┯ 0case2case0case1case2case21 ˆˆˆˆ
)]f┰,2┰,)/L(p,f,┰,┰,p2log[L(=┯ 0case0case1case2case21 ˆˆˆˆ
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Model Crohn's disease Ulcerative colitis
LogL ┰ 1case ┰ 2case p f 0case AICa LRT p -values LogL ┰ 1case ┰ 2case
Full -266.863 3.604 4.310 0.635 0.006 541.726 - -232.258 1.000 1.679
Null (no association) -272.188 - - 0.674 0.881 548.376 0.005
** -236.100 - -
Dominant -267.281 3.580 3.580 0.646 0.000 540.562 0.361 -235.704 1.310 1.310
Recessive -269.425 - 1.000 0.714 1.000 544.850 0.024
* -232.258 - 1.679
Additive -269.512 3.383 6.766 0.598 0.000 545.024 0.021
* -232.390 1.000 2.000
a 
The AIC is -2log L  + 2k , where k  is the number of estimated parameters.
b 
N. A.  means "not assessed" (there is no LRT p -values, because  LogL  value in Recessive model is equal to that in Full model).
* 
p -values < 0.05
** 
p -values < 0.01
w
w
w
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2.3.4 Population-specific susceptibility to IBD 
Given that CD and UC inheritance do not follow the typical Mendelian fashion, it is possible 
that the dominant/recessive effect of the risk allele (i.e. the biological roles of the disease 
etiology), as suggested by the mGRR test above, is shaped by the multiple genetic and 
environmental factors that are involved in each disease‘s mechanism. Recently, it has been 
argued that the reciprocal interaction between multiple genetic and environmental factors is 
important for complex diseases (Emison et al. 2005). The CD risk alleles identified in 
Europeans are absent – or not associated with CD – in the Japanese population, except for 
TNFSF15. Ethnic group-specific susceptibility is not a novel idea, and has generally been 
observed in complex diseases (Altshuler et al. 2008; Rosenberg et al. 2010; Bustamante et al. 
2011). Furthermore, the CD risk allele in TNFSF15 is also associated with UC in the Kyushu 
population. However, a previous study has found no association with UC at the same SNP 
in TNFSF15, using non-Kyushu Japanese subjects (Kakuta et al. 2006). These results imply 
that UC, as well as CD, may exhibit a population-specific susceptibility within the various 
Japanese subjects, similar to the susceptibility shown to exist between Japanese and 
European subjects. Using world-wide population samples, Myles et al. (2008) have 
examined the allele frequencies of complex diseases, including CD, and indicated the 
importance of geographic variation in disease-associated alleles (Myles et al. 2008). 
Specifically, allele frequencies have commonly been observed to be gradients among human 
populations (Tishkoff et al. 1996; Oota et al. 2004; Tishkoff and Kidd 2004; The International 
HapMap Consortium 2005; The International HapMap Consortium 2007), including the 
Japanese population (Yamaguchi-Kabata et al. 2008). Hence, allele frequencies fluctuate in 
each geographic region where environmental factors are different, and the population-
specific susceptibility of complex diseases might be reflected by subdivisions (i.e. 
subpopulations) among human populations. Population-specific genetic and environmental 
factors are likely to cause dominant or recessive genotype risks in each subpopulation. 
Therefore, it is necessary to investigate a greater number of local cases and controls in order 
to reveal the mechanisms of complex diseases. 
2.4 Evolutionary Insights into the geographic variation of IBD risk alleles 
Most of the genetic variants susceptible to complex diseases, including IBD, appeared before 
the divergences of human populations (Fig. 1b), and geographic gradients in allele 
frequencies are attributed to differences in evolutionary history, such as migration, changes 
in population size and natural selection among the populations. A representative example of 
a disease-causative allele maintained by environmental adaptation is that associated with 
sickle-cell anaemia, which causes severe anaemia, but its frequency is highly maintained in 
particular geographical regions because it confers resistance to malaria (Pasvol et al. 1978). 
Another example is the thrifty genotype hypothesis (Neel 1962) that the genetic 
predisposition to type II diabetes is the consequence of metabolic adaptations to an ancient 
lifestyle characterised by a fluctuating and unpredictable food supply and high levels of 
physical activity. With the switch to a sedentary lifestyle and energy-dense diets in civilised 
countries, the thrifty genotype is no longer advantageous and gives rise to disease 
phenotypes. The genetic variants that have been found to confer IBD risks point to the 
importance of innate immunity, autophagy and phagocytosis in IBD pathogenesis. Hence, 
we attribute population-specific IBD susceptibility to natural selection on the IBD variants, 
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or the other variation(s) closely linked to the IBD risk alleles (i.e. genetic hitchhiking) which 
might be an adaptation to pathogen infections in ancestral human populations. Indeed, CD 
risk alleles in NOD2 (rs2066844, rs2066845, and rs2066847) and in SLC22A4 (rs1050152) – all 
of them involve amino acid changes or frameshift – are completely absent in Japanese 
populations (Table 2), and possibly specific to European populations. These alleles might 
have been maintained only in European-ancestry populations by natural selection. To reveal 
the mechanisms of how IBD risk alleles are spread throughout human populations, in the 
near future we would like to collect detailed polymorphism data from geographically 
diverse populations so as to conduct evolutionary and population genetics analysis to detect 
the signal(s) of natural selection. 
Evolutionary insights into the genetic properties of individual risk alleles are useful for 
understanding how we can translate the results from GWAS in one population to other 
diverse populations so as to understand the similarities and differences among GWAS 
results in geographically separated populations. Hence, population genetic data and 
modelling efforts have had important roles in the characterization of disease alleles and in 
the planning of GWAS, respectively. More importantly, the current disease allele frequency 
and heterogeneity in IBD susceptible alleles among populations are the products of a long-
term human evolutionary history, and population-specific variants are likely to confer 
substantial risks of IBD in a particular population. Therefore, population-genetic modelling 
of the IBD risk alleles will highlight quantitative differences in population-specific 
mutations and provide a comprehensive catalogue of the intermediate variants, which are 
neither rare (< 1% in a population) nor common (> 5% in any populations), specific to a 
geographic region (Fig. 1b). 
3. Conclusion 
Among complex diseases, GWAS have produced numerous successes in identifying genes 
and genetic loci that contribute to IBD susceptibility. Despite distinct clinical features, 
approximately 30% of IBD-associated loci (28/99) are shared between UC and CD, 
indicating that these diseases engage common pathways and may be part of a mechanistic 
continuum (Khor et al. 2011). However, findings from GWAS in European-ancestry 
populations are not always easily translated into the rest of the world, which implies that 
the IBD-relevant biological pathways are different among geographic populations. Medical 
and evolutionary approaches are essential in the next phase of researches on human 
complex diseases. As to the medical studies, GWAS and whole-genome sequence 
approaches should incorporate geographically diverse populations and provide a 
comprehensive catalogue of candidate risk alleles. The important idea is that the worldwide 
human population and its distribution of disease-risk variation represent a singular 
outcome of human evolutionary history which will underlie future disease-mapping 
studies. Population-genetic modelling for disease alleles has become important in 
unravelling the reasons why the risk of IBD has remained within human populations. 
Evolutionary research should translate the outputs from large-scale medical studies to 
biological interpretations for the genetic backgrounds of IBD. As the technological barriers 
to the production of genomic data continue to fall, it can be hoped that the human genomics 
community will accept the challenge of capitalising on the full range of human diversity in 
the next wave of investigations of the variants that underlie IBD, since the expansion of our 
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understanding for human diversity is significant in the examination of any new aspects of 
genetic variation associated with IBD‘s pathogenesis. Therefore, evolutionary insights into 
IBD genetics will give a way to a paradigm of understanding inter-population and inter–
individual differences in these diseases mechanisms and of developing personalised 
medicine for the prevention of and care for IBD sufferers. 
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